The natural alkaloyd cyclopamine is the first discovered SMO inhibitor and has been largely used in CCA studies, providing early favorable data concerning the efficacy of targeting HH in this biliary tract neoplasia. The gene discussed is SMO; the disease is cholangiocarcinoma.